Syndax Pharmaceuticals (SNDX) Cash & Current Investments (2015 - 2026)
Syndax Pharmaceuticals (SNDX) recorded Cash & Current Investments of $547.86 million in Q2 2026, up 20.3% from $455.23 million a year earlier and up 55.6% from the prior quarter.
Syndax Pharmaceuticals (SNDX) Cash & Current Investments (2015 - 2026) Analysis & Trends
At the end of FY2025, Syndax Pharmaceuticals reported Cash & Current Investments of $394.07 million, down 31.2% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $572.88 million in FY2024 (+0.4%), $570.7 million in FY2023 (+19.9%), $475.8 million in FY2022 (+8.1%) and $440.05 million in FY2021 (+50.1%).
- The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q4 2024.
- On a year-over-year basis, Cash & Current Investments rose in six of the last eight quarters, with growth averaging 0.3%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 50.1% in Q4 2021, against a decline of 31.3% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $352.06 million (Q1 2026), $394.07 million (Q4 2025) and $435.98 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Syndax Pharmaceuticals | 1.57 Bn | -160.92 Mn | 69.58 Mn | 547.86 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 547.86 Mn |
| Mar 31, 2026 | 352.06 Mn |
| Dec 31, 2025 | 394.07 Mn |
| Sep 30, 2025 | 435.98 Mn |
| Jun 30, 2025 | 455.23 Mn |
| Mar 31, 2025 | 512.20 Mn |
| Dec 31, 2024 | 572.88 Mn |
| Sep 30, 2024 | 389.61 Mn |
| Jun 30, 2024 | 425.10 Mn |
| Mar 31, 2024 | 434.58 Mn |
| Dec 31, 2023 | 570.70 Mn |
| Sep 30, 2023 | 363.56 Mn |
| Jun 30, 2023 | 398.80 Mn |
| Mar 31, 2023 | 432.39 Mn |
| Dec 31, 2022 | 475.80 Mn |
| Sep 30, 2022 | 337.95 Mn |
| Jun 30, 2022 | 366.91 Mn |
| Mar 31, 2022 | 398.05 Mn |
| Dec 31, 2021 | 440.05 Mn |
| Sep 30, 2021 | 229.83 Mn |
Syndax Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SNDX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();